메뉴 건너뛰기




Volumn 22, Issue 5, 2011, Pages 429-435

Serum pharmacokinetics of clindamycin hydrochloride in normal dogs when administered at two dosage regimens

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

EID: 80052542007     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2011.00969.x     Document Type: Article
Times cited : (10)

References (47)
  • 1
    • 0037121270 scopus 로고    scopus 로고
    • Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden
    • Holm BR, Petersson U, Morner A et al. Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. The Veterinary Record 2002; 151: 600-5.
    • (2002) The Veterinary Record , vol.151 , pp. 600-605
    • Holm, B.R.1    Petersson, U.2    Morner, A.3
  • 2
    • 0027461995 scopus 로고
    • A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs
    • Harvey RG, Noble WC, Ferguson EA. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. The Veterinary Record 1993; 132: 351-3.
    • (1993) The Veterinary Record , vol.132 , pp. 351-353
    • Harvey, R.G.1    Noble, W.C.2    Ferguson, E.A.3
  • 3
    • 0036712059 scopus 로고    scopus 로고
    • Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997)
    • Petersen AD, Walker RD, Bowman MM et al. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). Journal of the American Animal Hospital Association 2002; 38: 407-13.
    • (2002) Journal of the American Animal Hospital Association , vol.38 , pp. 407-413
    • Petersen, A.D.1    Walker, R.D.2    Bowman, M.M.3
  • 4
    • 18944376981 scopus 로고    scopus 로고
    • Investigations into the basis of chloramphenicol and tetracycline resistance in Staphylococcus intermedius isolates from cases of pyoderma in dogs
    • Kim TJ, Na YR, Lee JI. Investigations into the basis of chloramphenicol and tetracycline resistance in Staphylococcus intermedius isolates from cases of pyoderma in dogs. Journal of Veterinary Medicine. B. Infectious Diseases and Veterinary Public Health 2005; 52: 119-24.
    • (2005) Journal of Veterinary Medicine. B. Infectious Diseases and Veterinary Public Health , vol.52 , pp. 119-124
    • Kim, T.J.1    Na, Y.R.2    Lee, J.I.3
  • 6
    • 33845234226 scopus 로고    scopus 로고
    • Species distribution and properties of staphylococci from canine dermatitis
    • Hauschild T, Wójcik A. Species distribution and properties of staphylococci from canine dermatitis. Research in Veterinary Science 2007; 82: 1-6.
    • (2007) Research in Veterinary Science , vol.82 , pp. 1-6
    • Hauschild, T.1    Wójcik, A.2
  • 7
    • 34548662622 scopus 로고    scopus 로고
    • Reclassification of phenotypically identified Staphylococcus intermedius strains
    • Sasaki T, Kikuchi K, Tanaka Y et al. Reclassification of phenotypically identified Staphylococcus intermedius strains. Journal of Clinical Microbiology 2007; 45: 2770-8.
    • (2007) Journal of Clinical Microbiology , vol.45 , pp. 2770-2778
    • Sasaki, T.1    Kikuchi, K.2    Tanaka, Y.3
  • 8
    • 36749006068 scopus 로고    scopus 로고
    • Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains
    • Bannoehr J, Ben Zakour NL, Waller AS et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. Journal of Bacteriology 2007; 189: 8685-92.
    • (2007) Journal of Bacteriology , vol.189 , pp. 8685-8692
    • Bannoehr, J.1    Ben Zakour, N.L.2    Waller, A.S.3
  • 9
    • 77956475573 scopus 로고    scopus 로고
    • In vitro antimicrobial efficacy of β-defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin
    • Fazakerley J, Crossley J, McEwan N et al. In vitro antimicrobial efficacy of β-defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin. Veterinary Dermatology 2010; 21: 463-8.
    • (2010) Veterinary Dermatology , vol.21 , pp. 463-468
    • Fazakerley, J.1    Crossley, J.2    McEwan, N.3
  • 10
    • 73149119560 scopus 로고    scopus 로고
    • The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance
    • Fitzgerald JR. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. Veterinary Dermatology 2009; 20: 490-5.
    • (2009) Veterinary Dermatology , vol.20 , pp. 490-495
    • Fitzgerald, J.R.1
  • 13
    • 0035159876 scopus 로고    scopus 로고
    • Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs
    • Bloom PB, Rosser EJ. Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs. Journal of the American Animal Hospital Association 2001; 37: 537-42.
    • (2001) Journal of the American Animal Hospital Association , vol.37 , pp. 537-542
    • Bloom, P.B.1    Rosser, E.J.2
  • 14
    • 0032411424 scopus 로고    scopus 로고
    • Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs
    • Scott DW, Beningo KE, Miller WH et al. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs. Canadian Veterinary Journal 1998; 39: 753-6.
    • (1998) Canadian Veterinary Journal , vol.39 , pp. 753-756
    • Scott, D.W.1    Beningo, K.E.2    Miller, W.H.3
  • 15
    • 14644440905 scopus 로고    scopus 로고
    • Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma
    • Ganiere JP, Medaille C, Mangion C. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. Journal of Veterinary Medicine Series B 2005; 52: 25-31.
    • (2005) Journal of Veterinary Medicine Series B , vol.52 , pp. 25-31
    • Ganiere, J.P.1    Medaille, C.2    Mangion, C.3
  • 16
    • 0031980604 scopus 로고    scopus 로고
    • Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas
    • Pellerin JL, Bourdeau P, Sebbag H et al. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comparative Immunology Microbiology and Infectious Diseases 1998; 21: 115-33.
    • (1998) Comparative Immunology Microbiology and Infectious Diseases , vol.21 , pp. 115-133
    • Pellerin, J.L.1    Bourdeau, P.2    Sebbag, H.3
  • 17
    • 0029868102 scopus 로고    scopus 로고
    • The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis
    • Kruse H, Hofshagen M, Thoresen SI et al. The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis. Veterinary Research Communications 1996; 20: 205-14.
    • (1996) Veterinary Research Communications , vol.20 , pp. 205-214
    • Kruse, H.1    Hofshagen, M.2    Thoresen, S.I.3
  • 18
    • 0022570118 scopus 로고
    • Frequency and antimicrobial susceptibility of Staphylococus species isolated from canine pyodermas
    • Medleau L, Long RE, Brown J et al. Frequency and antimicrobial susceptibility of Staphylococus species isolated from canine pyodermas. American Journal of Veterinary Research 1986; 47: 229-31.
    • (1986) American Journal of Veterinary Research , vol.47 , pp. 229-231
    • Medleau, L.1    Long, R.E.2    Brown, J.3
  • 19
    • 84995123571 scopus 로고
    • Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog
    • Noble WC, Kent LE. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Veterinary Dermatology 1992; 3: 71-4.
    • (1992) Veterinary Dermatology , vol.3 , pp. 71-74
    • Noble, W.C.1    Kent, L.E.2
  • 20
    • 0006990593 scopus 로고    scopus 로고
    • Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates
    • Stegemann M, Heukamp U, Scheer M et al. Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates. Compendium of Continuing Education for the Practicing Veterinarian 1996; 18(Supplement 1): 30-4.
    • (1996) Compendium of Continuing Education for the Practicing Veterinarian , vol.18 , Issue.SUPPLEMENT 1 , pp. 30-34
    • Stegemann, M.1    Heukamp, U.2    Scheer, M.3
  • 22
    • 0033549353 scopus 로고    scopus 로고
    • Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma
    • Littlewood JD, Lakhani KH, Paterson S et al. Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma. The Veterinary Record 1999; 144: 662-5.
    • (1999) The Veterinary Record , vol.144 , pp. 662-665
    • Littlewood, J.D.1    Lakhani, K.H.2    Paterson, S.3
  • 24
    • 0000722192 scopus 로고
    • Noncompartmental analysis based on statistical moment theory
    • New York: Marcel Dekker Inc.
    • Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. In: Pharmacokinetics. New York: Marcel Dekker Inc., 1982: 409-24.
    • (1982) Pharmacokinetics , pp. 409-424
    • Gibaldi, M.1    Perrier, D.2
  • 26
    • 0009996427 scopus 로고    scopus 로고
    • Factors affecting drug disposition and extrapolation of dosing regimens
    • Philadelphia, PA: W.B. Saunders
    • Boothe DM. Factors affecting drug disposition and extrapolation of dosing regimens. In: Small Animal Clinical Pharmacology and Therapeutics. Philadelphia, PA: W.B. Saunders, 2001: 18-40.
    • (2001) Small Animal Clinical Pharmacology and Therapeutics , pp. 18-40
    • Boothe, D.M.1
  • 29
    • 27844478779 scopus 로고    scopus 로고
    • Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs
    • Batzias GC, Delis GA, Athanasiou LV. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs. The Veterinary Journal 2005; 170: 339-45.
    • (2005) The Veterinary Journal , vol.170 , pp. 339-345
    • Batzias, G.C.1    Delis, G.A.2    Athanasiou, L.V.3
  • 30
    • 0032863486 scopus 로고    scopus 로고
    • Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs
    • Lavy E, Ziv G, Shem-Tov M et al. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs. Journal of Veterinary Pharmacology and Therapeutics 1999; 22: 261-5.
    • (1999) Journal of Veterinary Pharmacology and Therapeutics , vol.22 , pp. 261-265
    • Lavy, E.1    Ziv, G.2    Shem-Tov, M.3
  • 31
    • 27844517953 scopus 로고    scopus 로고
    • Oral absorption, bioavailability and tolerance study of clindamycin gel 3% in dogs
    • on CD Rom.
    • Lavy E, Shem-Tov M, Orbach A. Oral absorption, bioavailability and tolerance study of clindamycin gel 3% in dogs. Journal of Veterinary Pharmacology and Therapeutics 2000; 23 (Supplement 1): on CD Rom.
    • (2000) Journal of Veterinary Pharmacology and Therapeutics , vol.23 , Issue.SUPPLEMENT 1
    • Lavy, E.1    Shem-Tov, M.2    Orbach, A.3
  • 32
    • 80052554448 scopus 로고    scopus 로고
    • A retrospective analysis of clindamycin dosage regimens in dogs. Upjohn Technical Report 1977; no. 7254/77/7261/001: 17 November 1977.
    • Weber DJ. A retrospective analysis of clindamycin dosage regimens in dogs. Upjohn Technical Report 1977; no. 7254/77/7261/001: 17 November 1977.
    • Weber, D.J.1
  • 33
    • 80052521394 scopus 로고    scopus 로고
    • Clindamycin bioactivity following a multidose oral administration of Cleosin in dogs. Upjohn Technical Report 1978; no. 7254/78/7261/002: 16 March 1978.
    • Weber DJ, Barbiers AR, Henke CL. Clindamycin bioactivity following a multidose oral administration of Cleosin in dogs. Upjohn Technical Report 1978; no. 7254/78/7261/002: 16 March 1978.
    • Weber, D.J.1    Barbiers, A.R.2    Henke, C.L.3
  • 34
    • 0027066912 scopus 로고
    • Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations
    • Budsberg SC, Kemp DT, Wolski N. Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations. American Journal of Veterinary Research 1992; 53: 2333-6.
    • (1992) American Journal of Veterinary Research , vol.53 , pp. 2333-2336
    • Budsberg, S.C.1    Kemp, D.T.2    Wolski, N.3
  • 36
    • 0036671104 scopus 로고    scopus 로고
    • Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry
    • Cherlet M, Croubels S, De Backer P. Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry. Journal of Mass Spectrometry 2002; 37: 848-53.
    • (2002) Journal of Mass Spectrometry , vol.37 , pp. 848-853
    • Cherlet, M.1    Croubels, S.2    De Backer, P.3
  • 37
    • 0037636484 scopus 로고    scopus 로고
    • In vitro metabolism of clindamycin in human liver and intestinal microsomes
    • Wynalda MA, Hutzler JM, Koets MD et al. In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metabolism and Disposition 2003; 31: 878-87.
    • (2003) Drug Metabolism and Disposition , vol.31 , pp. 878-887
    • Wynalda, M.A.1    Hutzler, J.M.2    Koets, M.D.3
  • 38
    • 0015818152 scopus 로고
    • Metabolism of clindamycin. II. Urinary excretion products of clindamycin in rat and dog
    • Sun FF. Metabolism of clindamycin. II. Urinary excretion products of clindamycin in rat and dog. Journal of Pharmaceutical Sciences 1973; 62: 1657-62.
    • (1973) Journal of Pharmaceutical Sciences , vol.62 , pp. 1657-1662
    • Sun, F.F.1
  • 39
    • 52949101819 scopus 로고    scopus 로고
    • The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents
    • Giguere S, Prescott JF, Baggot JD, eds., 4th edn. Ames, IA: Blackwell Publishing
    • Martinez M, Toutain PL, Walker RD. The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents. In: Giguere S, Prescott JF, Baggot JD et al., eds. Antimicrobial Therapy in Veterinary Medicine, 4th edn. Ames, IA: Blackwell Publishing, 2006: 81-106.
    • (2006) Antimicrobial Therapy in Veterinary Medicine , pp. 81-106
    • Martinez, M.1    Toutain, P.L.2    Walker, R.D.3
  • 40
    • 0031036967 scopus 로고    scopus 로고
    • Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis
    • Klepser ME, Nicolau DP, Quintiliani R et al. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 1997; 41: 630-5.
    • (1997) Antimicrobial Agents and Chemotherapy , vol.41 , pp. 630-635
    • Klepser, M.E.1    Nicolau, D.P.2    Quintiliani, R.3
  • 41
    • 0036226169 scopus 로고    scopus 로고
    • Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations
    • Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents 2002; 19: 285-90.
    • (2002) International Journal of Antimicrobial Agents , vol.19 , pp. 285-290
    • Liu, P.1    Müller, M.2    Derendorf, H.3
  • 43
    • 0031952586 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
    • Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 1998; 26: 1-12.
    • (1998) Clinical Infectious Diseases , vol.26 , pp. 1-12
    • Craig, W.A.1
  • 44
    • 0032838506 scopus 로고    scopus 로고
    • Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
    • Lewis RE, Klepser ME, Ernst EJ et al. Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection. Antimicrobial Agents and Chemotherapy 1999; 43: 2005-9.
    • (1999) Antimicrobial Agents and Chemotherapy , vol.43 , pp. 2005-2009
    • Lewis, R.E.1    Klepser, M.E.2    Ernst, E.J.3
  • 45
    • 0030443051 scopus 로고    scopus 로고
    • Plasma disposition of clindamycin microbiological activity in cats after single oral doses of clindamycin hydrochloride as either capsules or aqueous solution
    • Boothe DM, Brown SA, Fate GD et al. Plasma disposition of clindamycin microbiological activity in cats after single oral doses of clindamycin hydrochloride as either capsules or aqueous solution. Journal of Veterinary Pharmacology and Therapeutics 1996; 19: 491-4.
    • (1996) Journal of Veterinary Pharmacology and Therapeutics , vol.19 , pp. 491-494
    • Boothe, D.M.1    Brown, S.A.2    Fate, G.D.3
  • 47
    • 19444385176 scopus 로고    scopus 로고
    • Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma
    • Hartmann FA, White DG, West SE et al. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Veterinary Microbiology 2005; 108: 119-31.
    • (2005) Veterinary Microbiology , vol.108 , pp. 119-131
    • Hartmann, F.A.1    White, D.G.2    West, S.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.